No Data
No Data
J.P. Morgan Chase sold 989,900 H shares of Yao Ming Kangde (02359.HK), worth about HK$36.618 million
On April 18, it was reported that according to documents disclosed by the Hong Kong Stock Exchange on April 18, JPMorgan Chase & Co. (JPMorgan Chase & Co.) sold $980,900 H shares worth HK$36.11,800 on April 15 at an average price of HK$34.2659 per share and an average OTC share of HK$34.2333. After the sale, the latest number of shares held by J.P. Morgan Chase was 33.981 million shares, and the good position ratio dropped from 9.01% to 8.76%. Photo source: What does the Stock Exchange's shares disclose
Yao Ming Kangde (02359.HK) spent 2005 million yuan to buy back 474,200 A shares on April 19
On April 19, Ge Longhui (02359.HK) issued an announcement. On April 19, 2024, it spent RMB 2005 million yuan to buy back 474,200 A shares, with a repurchase price of 41.88-42.9 yuan per share.
Xiaomo reduced its holdings of Medicinal Kangde (02359.HK) by about 989,900 shares at a price of about HK$34.27 per share
According to the latest data from the Hong Kong Stock Exchange, on April 15, Xiaomao reduced its holdings of Pharmaceutical Kangde (02359.HK) by 989.11 million shares, at a price of HK$34.2659 per share, for a total amount of about HK$33.611,800. After the holdings were reduced, the latest number of shares held was approximately 33.981 million shares, and the latest shareholding ratio was 8.76%.
Hong Kong Stock Afternoon Review | The three major indices fell sharply, auto stocks fell, and Ideal Auto fell by more than 7%
Technology and network stocks generally fell; Xiaomi fell more than 4%, Meituan fell nearly 4%; shipping stocks rose higher, Pacific Shipping rose more than 9%, and COSCO Haineng rose more than 5%.
Express News | Hong Kong Stock Afternoon Review: Hang Seng Technology Index fell 2.6%, Xiaomi Group, Pharmaceutical & Kangde fell more than 4%
Changes in Hong Kong stocks | CRO concept stocks continue to decline, the Federal Reserve does not rule out possible interest rate hikes, domestic innovative drugs are still in an adjustment cycle
CRO concept stocks continued to decline. As of press release, Tiger Pharmaceuticals (03347.HK) fell 7.94% to HK$28.4; Kingsley Biotech (01548.HK) fell 5.93% to HK$10.78; Kanglong Chemical (03759.HK) fell 4.83% to HK$8.47; and Pharmaceuticals (02359.HK) fell 4.5% to HK$32.9.
No Data